Juniper Pharma Revenue, Profits - JNP Quarterly Income Statement

Add to My Stocks
$11.5 $0 (0%) JNP stock closing price Aug 14, 2018 (Closing)

Looking at financial statements, along with the Juniper Pharma stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the JNP stock is bound to reflect the impact of the QOQ decline of -1.35%. Along with Juniper Pharma assets and Juniper Pharma free cash flow, Juniper Pharma profits as shown in profit and loss statement give key insights about the business. The net profit for 2018 Q2 is $-1.51M and the 2018 Q2 revenue is $15.31M.

View and download details of revenue and profits for Juniper Pharma for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Juniper Pharma Revenues or Net Sales
15.31M15.52M11.79M12.99M13.96M11.25M20.93M11.56M11.89M12.1M
Cost Of Goods Sold (COGS)9.11M9.02M7.05M7.71M7.65M6.55M5.78M5.7M6.46M6.35M
Juniper Pharma Gross Profit
6.19M6.49M4.76M5.26M6.3M4.69M13.27M5.85M5.41M5.75M
Research & Development Expense1.05M-1.59M2.29M1.64M1.34M2.07M2.3M3.55M1.75M
Selling General & Admin Expense7.08M4.5M3.7M4.51M5.01M4.8M4.6M3.37M3.62M3.73M
Income Before Depreciation Depletion Amortization-1.94M1.01M-0.53M-1.53M-0.35M-1.45M6.59M--1.75M-
Depreciation Depletion Amortization----------
Non Operating Income--0.19M1.57M-------
Interest Expense----------
Juniper Pharma Pretax Income
-1.21M-1.02M-1.45M-0.37M-1.44M7.13M--1.69M-
Provision for Income Taxes---0.14M-0.04M----0.01M--
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-1.51M-1.17M-1.41M-0.38M-1.44M9.61M--1.75M-
Extraordinary Items & Discontinued Operations----------
Juniper Pharma Profit/ Loss (Net Income)
-1.51M-1.17M-1.41M-0.38M-1.44M9.61M--1.75M-
Average Shares used to compute Diluted EPS11.1M12.29M10.99M10.84M10.95M10.8M10.91M11.06M10.79M10.79M
Average Shares used to compute Basic EPS11.1M10.94M10.84M10.84M10.8M10.8M10.8M10.8M10.79M10.79M
Income Before Nonrecurring Items-1.51M-1.17M-0.92M-0.38M-1.44M9.61M--1.75M-
Income from Nonrecurring Items----0.49M------
Juniper Pharma Earnings Per Share Basic Net
-0.140.070.11-0.130.01-0.130.890.02-0.160.03
Juniper Pharma Earnings Per Share Diluted Net
-0.140.060.11-0.13-0.03-0.130.880.02-0.160.03
EPS Diluted Before Nonrecurring Items-0.140.060.11-0.08-0.03-0.130.880.02-0.160.03
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The key things to look for in an income statement while doing Juniper Pharma stock analysis are:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Juniper Pharma revenue chart, implies that the company is growing. It has not been the case with Juniper Pharma. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: Most businesses like Juniper Pharma try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The JNP financials along with Juniper Pharma historical stock prices provide a lot of details about the firm.

Juniper Pharma Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
2.26
Dividend Yield
0%